Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
about
In vivo administration of a JAK3 inhibitor to chronically siv infected rhesus macaques leads to NK cell depletion associated with transient modest increase in viral loads.Novel hinge-binding motifs for Janus kinase 3 inhibitors: a comprehensive structure-activity relationship study on tofacitinib bioisosteres.Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review.Selective JAK inhibitors.Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1.Signal transducer and activator of transcription 5 is implicated in disease activity in adult and juvenile onset systemic lupus erythematosus.Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular dynamics simulation.A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes.Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-d]pyrimidine scaffold: evaluation of WO2013085802.Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore- and docking-based virtual screening approach.Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate.
P2860
Q34907640-B8525794-0E2B-4FA4-918E-87B4550087FDQ35228409-088E69F1-73C7-41B2-A55C-997897A6C042Q37519638-DA5089AD-84A5-4CC3-B196-1B3FEBD7E07CQ38183162-2DB28A94-5A6A-4FAD-B319-005CC5AD2EAAQ38261371-97A9705D-FE35-43B0-898D-BF8E32228F50Q38989227-EC00C2DC-4DAC-4258-839B-C6040A94A79BQ39246970-32C39B78-4B9A-4A6B-A746-CE62EF2C3D00Q40188503-4D4147F3-A04A-4021-9D50-E151BD06B304Q43135354-2DF26F68-624F-4ED3-8EF6-BC7C41BFCD8AQ45332740-A48B4B8C-D5E1-4B1E-8FB6-7EABA5351AB3Q46460981-60079CE8-46CD-483E-9F73-562F08A07A6BQ51759248-4937C441-3EA2-4B0F-A779-F169AE5EBC23Q55310713-F1101516-AD5C-4C90-BC20-5F5530C19C34
P2860
Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
@en
type
label
Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
@en
prefLabel
Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
@en
P2860
P1476
Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
@en
P2093
Brian W Dymock
Cheng Shang See
P2860
P304
P356
10.1517/13543776.2013.765862
P407
P577
2013-02-01T00:00:00Z